Realist Pharma

Realist Pharma

Developing oncology-focused therapeutics that treat a wide range of cancers with its main programs being REAL-1 (a “next gen CAR-T” cell therapy) and REAL-2 (NCE cancer vaccines), both of which target >10 highly prevalent tumor markers.

Area of focus: 
Oncology
Commencement date: 
06/01/2016

Contact

  • Mark de Groot

    CEO

Share